Shanghai Haohai Biological Technology Purchases Full Stake in Lens Maker
MT Newswires Live
Nov 10
Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) subsidiary Shanghai Haohai Medical Technology Development purchased the remaining 20% stake in Shenzhen New Industries Material of Ophthalmology from its sellers, according to a Monday filing with the Shanghai bourse.
Sellers Shenzhen Baina Tongda Investment Consulting Partnership, Shenzhen Jiusi Investment Partnership and Shenzhen New Industries Material of Ophthalmology director Zhang Jinsong sold the stake for 74 million yuan.
Once the acquisition is completed, Haohai will hold 100% in the lens manufacturer.
Shares rose 2% in Shanghai during afternoon trading on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.